ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Six Contract Recompetitions

October 23, 1987

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

Clinton Administration Issues Research Misconduct Policy.

December 8, 2000

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

AACI’s “12 Tasks” Outlined to Board

March 28, 1975